Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Bioventus Inc. (BVS) had Normalized Income after Taxes of $-43.83M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$573.28M |
|
$-33.54M |
|
$185.05M |
|
$388.23M |
|
$585.26M |
|
$-11.98M |
|
$-37.15M |
|
$-49.13M |
|
$-49.13M |
|
$-43.83M |
|
$-43.83M |
|
$-43.83M |
|
|
Normalized Income after Taxes |
$-43.83M |
$-11.98M |
|
$37.58M |
|
64.55M |
|
64.55M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$275.61M |
|
$27.01M |
|
$452.35M |
|
$727.96M |
|
$210.40M |
|
$308.29M |
|
$331.95M |
|
$542.35M |
|
$185.60M |
|
$-226.59M |
|
$185.60M |
|
81.55M |
|
| Cash Flow Statement Financials | |
$38.80M |
|
$22.96M |
|
$-54.58M |
|
$36.96M |
|
$41.58M |
|
$4.62M |
|
$10.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
0.62 |
|
1.81 |
|
67.72% |
|
-2.09% |
|
-2.09% |
|
6.55% |
|
-8.57% |
|
-5.85% |
|
$37.79M |
|
-- |
|
-- |
|
-- |
|
0.79 |
|
2.00 |
|
4.50 |
|
81.11 |
|
-23.62% |
|
19.34% |
|
-6.02% |
|
-8.88% |
|
$2.28 |
|
$0.59 |
|
$0.60 |
|